Grey Matters Health Inc. (AGNPF)
Grey Matters Health Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.31, up 0.00% on the session, giving a market capitalisation of $1.7M. Its beta of 0.27 implies it has historically moved less than the broad market.
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Grey Matters Health Inc. is most often compared with the following Healthcare names: